The knockdown of both GSK3α and GSK3β resulted in aggressive AML [92], although GSK3α deletion alone had no effect on hematopoiesis, and deletion of GSK3β resulted in myelodysplastic syndromes. The gene discussed is GSK3B; the disease is myelodysplastic syndrome.